Dina Masi

2022

In 2022, Dina Masi earned a total compensation of $300.2K as Chief Financial Officer and Senior Vice President at Integrated Biopharma, a 12% increase compared to previous year.

Compensation breakdown

Option Awards$36,905
Salary$253,762
Other$9,571
Total$300,238

Masi received $253.8K in salary, accounting for 85% of the total pay in 2022.

Masi also received $36.9K in option awards and $9.6K in other compensation.

Rankings

In 2022, Dina Masi's compensation ranked 5,026th out of 5,669 executives tracked by ExecPay. In other words, Masi earned more than 11.3% of executives.

ClassificationRankingPercentile
All
5,026
out of 5,669
11th
Division
Manufacturing
2,771
out of 3,081
10th
Major group
Chemicals And Allied Products
1,290
out of 1,396
8th
Industry group
Drugs
1,211
out of 1,297
7th
Industry
Pharmaceutical Preparations
876
out of 940
7th
Source: SEC filing on October 27, 2022.

Masi's colleagues

We found four more compensation records of executives who worked with Dina Masi at Integrated Biopharma in 2022.

2022

E Kay

Integrated Biopharma

Chairman

2022

EGerald Kay

Integrated Biopharma

Chairman

2022

Riva Sheppard

Integrated Biopharma

Chief Executive Officer

2022

Christina Kay

Integrated Biopharma

Chief Executive Officer

News

You may also like